AstraZeneca scores win in race to treat ovarian cancer

AstraZeneca has made further headway in the race with larger competitor GlaxoSmithKline's to use a promising new class of drugs to treat ovarian cancer.

from Reuters: Health News https://ift.tt/2yYVObG
via IFTTT